Literature DB >> 26640151

Molecular mechanisms of target recognition by lipid GPCRs: relevance for cancer.

M T M van Jaarsveld1, J M Houthuijzen1, E E Voest1.   

Abstract

Over the past decade the importance of lipids for cancer cell metabolism and cancer-related processes such as proliferation, metastasis and chemotherapy resistance has become more apparent. The mechanisms by which lipid signals are transduced are poorly understood, but frequently involve G-protein Coupled Receptors (GPCRs), which can be explored as druggable targets. Here, we discuss how GPCRs recognize four classes of cancer-relevant lipids (lysophospholipids, phospholipids, fatty acids and eicosanoids). We compare the ligand-binding properties of >50 lipid receptors, we examine how their dysregulation contributes to tumorigenesis and how they may be therapeutically exploited.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26640151     DOI: 10.1038/onc.2015.467

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  344 in total

1.  Identification of domains conferring ligand binding specificity to the prostanoid receptor. Studies on chimeric prostacyclin/prostaglandin D receptors.

Authors:  T Kobayashi; M Kiriyama; T Hirata; M Hirata; F Ushikubi; S Narumiya
Journal:  J Biol Chem       Date:  1997-06-13       Impact factor: 5.157

2.  Identification, molecular cloning, expression, and characterization of a cysteinyl leukotriene receptor.

Authors:  H M Sarau; R S Ames; J Chambers; C Ellis; N Elshourbagy; J J Foley; D B Schmidt; R M Muccitelli; O Jenkins; P R Murdock; N C Herrity; W Halsey; G Sathe; A I Muir; P Nuthulaganti; G M Dytko; P T Buckley; S Wilson; D J Bergsma; D W Hay
Journal:  Mol Pharmacol       Date:  1999-09       Impact factor: 4.436

Review 3.  Lysophospholipid receptors: signalling, pharmacology and regulation by lysophospholipid metabolism.

Authors:  Dagmar Meyer zu Heringdorf; Karl H Jakobs
Journal:  Biochim Biophys Acta       Date:  2006-10-04

4.  Molecular characterization of a mouse prostaglandin D receptor and functional expression of the cloned gene.

Authors:  M Hirata; A Kakizuka; M Aizawa; F Ushikubi; S Narumiya
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

Review 5.  The prostanoid EP4 receptor and its signaling pathway.

Authors:  Utako Yokoyama; Kousaku Iwatsubo; Masanari Umemura; Takayuki Fujita; Yoshihiro Ishikawa
Journal:  Pharmacol Rev       Date:  2013-06-17       Impact factor: 25.468

6.  Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43.

Authors:  Kendle M Maslowski; Angelica T Vieira; Aylwin Ng; Jan Kranich; Frederic Sierro; Di Yu; Heidi C Schilter; Michael S Rolph; Fabienne Mackay; David Artis; Ramnik J Xavier; Mauro M Teixeira; Charles R Mackay
Journal:  Nature       Date:  2009-10-29       Impact factor: 49.962

7.  Sphingosine-1-phosphate receptor type 1 regulates glioma cell proliferation and correlates with patient survival.

Authors:  Yuya Yoshida; Mitsutoshi Nakada; Naotoshi Sugimoto; Tomoya Harada; Yasuhiko Hayashi; Daisuke Kita; Naoyuki Uchiyama; Yutaka Hayashi; Akihiro Yachie; Yoh Takuwa; Jun-Ichiro Hamada
Journal:  Int J Cancer       Date:  2010-05-15       Impact factor: 7.396

8.  Activation of the leukotriene B4 receptor 2-reactive oxygen species (BLT2-ROS) cascade following detachment confers anoikis resistance in prostate cancer cells.

Authors:  Jin-Wook Lee; Jae-Hong Kim
Journal:  J Biol Chem       Date:  2013-08-28       Impact factor: 5.157

Review 9.  Role of the autotaxin-lysophosphatidate axis in cancer resistance to chemotherapy and radiotherapy.

Authors:  David N Brindley; Fang-Tsyr Lin; Gabor J Tigyi
Journal:  Biochim Biophys Acta       Date:  2012-08-29

10.  Identification of a novel human eicosanoid receptor coupled to G(i/o).

Authors:  Takeshi Hosoi; Yutaka Koguchi; Emiko Sugikawa; Aiko Chikada; Koji Ogawa; Naoki Tsuda; Naoki Suto; Shiho Tsunoda; Tomoyasu Taniguchi; Tetsuo Ohnuki
Journal:  J Biol Chem       Date:  2002-06-13       Impact factor: 5.157

View more
  7 in total

1.  Prospective serum metabolomic profile of prostate cancer by size and extent of primary tumor.

Authors:  Jiaqi Huang; Alison M Mondul; Stephanie J Weinstein; Edward D Karoly; Joshua N Sampson; Demetrius Albanes
Journal:  Oncotarget       Date:  2017-07-11

2.  Serum lipidomic study reveals potential early biomarkers for predicting response to chemoradiation therapy in advanced rectal cancer: A pilot study.

Authors:  Piero Del Boccio; Francesca Perrotti; Claudia Rossi; Ilaria Cicalini; Sara Di Santo; Mirco Zucchelli; Paolo Sacchetta; Domenico Genovesi; Damiana Pieragostino
Journal:  Adv Radiat Oncol       Date:  2017-01-05

3.  GPCRomics: GPCR Expression in Cancer Cells and Tumors Identifies New, Potential Biomarkers and Therapeutic Targets.

Authors:  Paul A Insel; Krishna Sriram; Shu Z Wiley; Andrea Wilderman; Trishna Katakia; Thalia McCann; Hiroshi Yokouchi; Lingzhi Zhang; Ross Corriden; Dongling Liu; Michael E Feigin; Randall P French; Andrew M Lowy; Fiona Murray
Journal:  Front Pharmacol       Date:  2018-05-22       Impact factor: 5.810

4.  Mapping the Molecular Architecture Required for Lipid-Binding Pockets Using a Subset of Established and Orphan G-Protein Coupled Receptors.

Authors:  Shanthi Nagarajan; Zu Yuan Qian; Parthiban Marimuthu; Nabil J Alkayed; Sanjiv Kaul; Anthony P Barnes
Journal:  J Chem Inf Model       Date:  2021-07-09       Impact factor: 6.162

Review 5.  Soluble Epoxide Hydrolase Regulation of Lipid Mediators Limits Pain.

Authors:  Karen M Wagner; Aldrin Gomes; Cindy B McReynolds; Bruce D Hammock
Journal:  Neurotherapeutics       Date:  2020-07       Impact factor: 6.088

6.  Synthesis and preclinical validation of novel P2Y1 receptor ligands as a potent anti-prostate cancer agent.

Authors:  Hien Thi Thu Le; Tatu Rimpilainen; Saravanan Konda Mani; Akshaya Murugesan; Olli Yli-Harja; Nuno R Candeias; Meenakshisundaram Kandhavelu
Journal:  Sci Rep       Date:  2019-12-12       Impact factor: 4.379

Review 7.  Recent Advances in Structure, Function, and Pharmacology of Class A Lipid GPCRs: Opportunities and Challenges for Drug Discovery.

Authors:  R N V Krishna Deepak; Ravi Kumar Verma; Yossa Dwi Hartono; Wen Shan Yew; Hao Fan
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.